Home > Qtrly Results > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Quarterly Results Analysis [Sep2023]

DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Quarterly Results

Consolidated Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Dec2021
UnAudited
Revenues ₹6,903 Cr ₹6,758 Cr ₹6,315 Cr ₹6,790 Cr ₹6,332 Cr ₹5,233 Cr ₹5,475 Cr ₹5,338 Cr
Expenses ₹4,894 Cr ₹4,696 Cr ₹4,781 Cr ₹4,851 Cr ₹4,433 Cr ₹4,292 Cr ₹5,024 Cr ₹4,123 Cr
Operating Income ₹2,008 Cr ₹2,062 Cr ₹1,534 Cr ₹1,939 Cr ₹1,899 Cr ₹941 Cr ₹451 Cr ₹1,216 Cr
Other Income ₹315 Cr ₹174 Cr ₹139 Cr ₹59 Cr ₹41 Cr ₹854 Cr ₹122 Cr ₹56 Cr
Interest ₹35 Cr ₹37 Cr ₹35 Cr ₹42 Cr ₹31 Cr ₹35 Cr ₹32 Cr ₹22 Cr
Depreciation ₹376 Cr ₹353 Cr ₹316 Cr ₹324 Cr ₹309 Cr ₹302 Cr ₹293 Cr ₹294 Cr
Profit Before Tax ₹1,913 Cr ₹1,846 Cr ₹1,322 Cr ₹1,632 Cr ₹1,600 Cr ₹1,459 Cr ₹248 Cr ₹956 Cr
Profit After Tax ₹1,478 Cr ₹1,401 Cr ₹953 Cr ₹1,238 Cr ₹1,100 Cr ₹1,180 Cr ₹87 Cr ₹691 Cr
EPS ₹88.86 ₹84.33 ₹57.63 ₹74.66 ₹66.96 ₹71.45 ₹5.83 ₹42.63
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES 0.5% 5.3% 28%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 7.2% 17.6%
DIVIS LABORATORIES 1% 10.2% 14.1%
CIPLA -4.9% 1.6% 8.3%
TORRENT PHARMACEUTICALS -1.9% 8.2% 29.1%
ABBOTT INDIA -0.9% 4.7% 20.4%
ZYDUS LIFESCIENCES -1.4% 9.6% 62.4%
ALKEM LABORATORIES 1.4% 23.9% 45.8%
LUPIN 1.8% 10% 72.9%

DR REDDYS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

2.14 %

Y-o-Y

9.01 %

Quarters Revenues % Change
Sep2023 ₹6,903 Cr
2.14
Jun2023 ₹6,758 Cr
7.01
Mar2023 ₹6,315 Cr
-6.99
Dec2022 ₹6,790 Cr
7.23
Sep2022 ₹6,332 Cr
21.00
Jun2022 ₹5,233 Cr
-4.42
Mar2022 ₹5,475 Cr
2.56
Dec2021 ₹5,338 Cr -

DR REDDYS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-2.61 %

Y-o-Y

5.76 %

Quarters Operating Profit % Change
Sep2023 ₹2,008 Cr
-2.61
Jun2023 ₹2,062 Cr
34.44
Mar2023 ₹1,534 Cr
-20.87
Dec2022 ₹1,939 Cr
2.09
Sep2022 ₹1,899 Cr
101.75
Jun2022 ₹941 Cr
108.69
Mar2022 ₹451 Cr
-62.90
Dec2021 ₹1,216 Cr -
Operating Margins
Q-o-Q

-4.65 %

Y-o-Y

-3.00 %

Quarters Operating Margin% % Change
Sep2023 29.09%
-4.65
Jun2023 30.51%
25.61
Mar2023 24.29%
-14.92
Dec2022 28.55%
-4.80
Sep2022 29.99%
66.70
Jun2022 17.99%
118.33
Mar2022 8.24%
-63.81
Dec2021 22.77% -

DR REDDYS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

5.52 %

Y-o-Y

34.34 %

Quarters Profit After Tax % Change
Sep2023 ₹1,478 Cr
5.52
Jun2023 ₹1,401 Cr
47.06
Mar2023 ₹953 Cr
-23.06
Dec2022 ₹1,238 Cr
12.52
Sep2022 ₹1,100 Cr
-6.73
Jun2022 ₹1,180 Cr
1,263.70
Mar2022 ₹87 Cr
-87.48
Dec2021 ₹691 Cr -
PAT Margins
Q-o-Q

3.28 %

Y-o-Y

23.19 %

Quarters PAT Margin(%) % Change
Sep2023 21.41 %
3.28
Jun2023 20.73 %
37.47
Mar2023 15.08 %
-17.28
Dec2022 18.23 %
4.89
Sep2022 17.38 %
-22.89
Jun2022 22.54 %
1,326.58
Mar2022 1.58 %
-87.79
Dec2021 12.94 % -

DR REDDYS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

5.37 %

Y-o-Y

32.71 %

Quarters EPS % Change
Sep2023 ₹88.86
5.37
Jun2023 ₹84.33
46.33
Mar2023 ₹57.63
-22.81
Dec2022 ₹74.66
11.50
Sep2022 ₹66.96
-6.28
Jun2022 ₹71.45
1,125.56
Mar2022 ₹5.83
-86.32
Dec2021 ₹42.63 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].